LPTX - Leap Therapeutics Inc
IEX Last Trade
2.895
0.065 2.245%
Share volume: 45,757
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.83
0.07
2.30%
Fundamental analysis
29%
Profitability
43%
Dept financing
15%
Liquidity
50%
Performance
15%
Performance
5 Days
6.62%
1 Month
33.03%
3 Months
22.88%
6 Months
1.75%
1 Year
26.09%
2 Year
-79.14%
Key data
Stock price
$2.90
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.24 - $5.00
52 WEEK CHANGE
$0.31
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO:
Region: US
Website: https://www.leaptx.com/
Employees: 34
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.leaptx.com/
Employees: 34
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
Recent news